Literature DB >> 7844590

Ifosfamide: should the honeymoon be over?

B A Kamen, E Frenkel, O M Colvin.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7844590     DOI: 10.1200/JCO.1995.13.2.307

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

Review 1.  Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites.

Authors:  T Kerbusch; J de Kraker; H J Keizer; J W van Putten; H J Groen; R L Jansen; J H Schellens; J H Beijnen
Journal:  Clin Pharmacokinet       Date:  2001-01       Impact factor: 6.447

2.  6-Day continuous infusion of high-dose ifosfamide with bone marrow growth factors in advanced refractory malignancies.

Authors:  E C Brain; A Mita; P Soulié; H Errihani; A C Hardy Bessard; M Chaouche; J Alexandre; J P Delord; E Cvitkovic; C Jasmin; J L Misset
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

Review 3.  The development of VAC chemotherapy in rhabdomyosarcoma: what does one do for an encore?

Authors:  Frederick B Ruymann
Journal:  Curr Oncol Rep       Date:  2003-11       Impact factor: 5.075

4.  Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancer.

Authors:  I Willits; L Price; A Parry; M J Tilby; D Ford; S Cholerton; A D J Pearson; A V Boddy
Journal:  Br J Cancer       Date:  2005-05-09       Impact factor: 7.640

5.  Modulation of P450-dependent ifosfamide pharmacokinetics: a better understanding of drug activation in vivo.

Authors:  E G Brain; L J Yu; K Gustafsson; P Drewes; D J Waxman
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

6.  Treatment of advanced seminoma with cyclophosphamide, vincristine and carboplatin on an outpatient basis.

Authors:  S Sleijfer; P H Willemse; E G de Vries; W T van der Graaf; H Schraffordt Koops; N H Mulder
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.